BCLI target price at $6.35 +24%

NASDAQ:BCLI   Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics has activated a falling wedge with price target at $6.35 +24% from current price and also deactivated a second bearish impulse.
Trade closed: target reached


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.